How many clinical trials are studying Neoadjuvant Chemotherapy in Combination with Toripalimab?

3 recruiting trials in our tracked data involve Neoadjuvant Chemotherapy in Combination with Toripalimab.

Neoadjuvant Chemotherapy in Combination with Toripalimab: clinical trials recruiting now

Q: What conditions is Neoadjuvant Chemotherapy in Combination with Toripalimab being studied for?

In our tracked recruiting trials, Neoadjuvant Chemotherapy in Combination with Toripalimab is being studied in trials for Breast cancer, HR+/HER2- Breast Cancer, HR Positive/HER2 Low Breast Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 2 Phase 3 1

Conditions being studied

Condition	Trials
Breast cancer · Neoadjuvant Chemotherapy in Combination with Toripalimab for Breast cancer	3
HR+/HER2- Breast Cancer	2
HR Positive/HER2 Low Breast Cancer	1

Recruiting trials involving Neoadjuvant Chemotherapy in Combination with Toripalimab

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
NCT06611813 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 11 locations
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
NCT06977893 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 13 locations
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
NCT07383818 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 5 locations

Common questions

How many recruiting trials involve Neoadjuvant Chemotherapy in Combination with Toripalimab?

3 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.